Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2012

Oct 15, 2012

35124_dirs_2012-10-15_ae099b76-ee87-49a1-b0e1-e4f231aeb5b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-10-15

Reporting Person: Martinez Alberto R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-10-15 Celsion Corporation Common Stock M 34542 $2.77 Acquired 119542 Direct
2012-10-15 Celsion Corporation Common Stock M 2500 $2.36 Acquired 122042 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-10-15 Warrants to purchase Celsion Corporation Common Stock $2.77 X 34542 Disposed 2017-05-26 Celsion Corporation Common Stock (34542) Direct
2012-10-15 Warrants to purchase Celsion Corporation Common Stock $2.36 X 2500 Disposed 2016-12-06 Celsion Corporation Common Stock (2500) Direct

Footnotes

F1: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the May 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.77 per share. The Director has no immediate intent to sell these newly acquired shares.

F2: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the December 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.36 per share. The Director has no immediate intent to sell these newly acquired shares.